Online inquiry

IVTScrip™ mRNA-Human AAGAB, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8713MR)

This product GTTS-WK8713MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AAGAB protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001271885.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 79719
UniProt ID Q6PD74
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AAGAB, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8713MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK28233MR IVTScrip™ mRNA-Human APOL1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA APOL1
GTTS-WK24288MR IVTScrip™ mRNA-Human ATP1B4, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ATP1B4
GTTS-WK12308MR IVTScrip™ mRNA-Human A2M, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA A2M
GTTS-WK20587MR IVTScrip™ mRNA-Human ANKH, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKH
GTTS-WK14143MR IVTScrip™ mRNA-Human ABCB9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABCB9
GTTS-WK17888MR IVTScrip™ mRNA-Human ANKHD1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKHD1
GTTS-WK19375MR IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA Androgen-binding protein
GTTS-WK15845MR IVTScrip™ mRNA-Human ANO10, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANO10
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW